Natera
Announced 06 Apr 2015$55.5M · private financing · Biotechnology Research · United States
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health.
“Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type”
4 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: Sofinnova Ventures (lead), Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners, OrbiMed Advisors.